Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2026 407

  1. Primary completion Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06341452

  2. Study completion Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06374823

  3. Primary completion Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06374823

  4. Study completion Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06376916

  5. Primary completion Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06376916

  6. Study completion Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06402851

  7. Primary completion Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06402851

  8. Study completion NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06403267

  9. Primary completion NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06403267

  10. Study completion Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06424834

  11. Primary completion Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06424834

  12. Primary completion Henagliflozin's Impact on Prediabetes Remission Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06448130

  13. Study completion Beta-Blockers in Takotsubo Syndrome Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06509074

  14. Study completion Evaluation of Clinical Impact of the Type of Cardioplegia Used in the Patient Undergoing Major Cardiac Surgery. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06530641

  15. Study start International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06566183

  16. Study completion BIO|MASTER.CSP Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06620237

  17. Study completion Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06688396

  18. Primary completion Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06688396

  19. Primary completion Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06689839

  20. Study completion A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06713239

  21. Primary completion A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06713239

  22. Primary completion Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06756945

  23. Study completion National Trial of CGM in Pregnant Women With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06903728

  24. Primary completion National Trial of CGM in Pregnant Women With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06903728

  25. Primary completion Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06917664

  26. Primary completion Formoterol in Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07022418

  27. Study completion A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07023614

  28. Primary completion A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07023614

  29. Primary completion Semaglutide for Smoking Cessation in Patients With Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07059377

  30. Primary completion Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07093476

  31. Study completion The Clinical Application of Peripheral Embolization Coil Systems in Arteriovenous Embolization Within the Peripheral Vasculature Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07156409

  32. Study completion Clinical validatiOn of an AI-based DEcision Support System for Robotic Upper Limb Rehabilitation in Patients With Stroke. A CO-AIDER Study. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07199322

  33. Primary completion Clinical validatiOn of an AI-based DEcision Support System for Robotic Upper Limb Rehabilitation in Patients With Stroke. A CO-AIDER Study. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07199322

  34. Study completion A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07215312

  35. Study start REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07216170

  36. Study completion Antihypertensive Drug Selection Based on Hemodynamic Phenotypes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07240909

  37. Primary completion Antihypertensive Drug Selection Based on Hemodynamic Phenotypes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07240909

  38. Study completion A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07311551

  39. Primary completion A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07311551

  40. Primary completion The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07381803

  41. Primary completion Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07487103

  42. Primary completion QLS1410 in Participants With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07489612

  43. Primary completion Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07511361

  44. Study start Regression in Left Ventricular Hypertrophy and Fibrosis in Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07539259

  45. Study completion Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07579390

  46. Primary completion Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07579390

  47. Study completion Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07581210

  48. Primary completion Management of Iron Deficiency Anemia in Hemodialysis Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07706582

  49. Study start Evaluation of the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07714876

  50. Study start IV-X Medical Peripheral Intravascular Lithotripsy Study for PAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07746362

  51. Study start DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07764016

  52. Study start Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07766109

  53. Study start Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07828730

  54. Primary completion AI-Based Personalized Self-Management for Patients With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07841665

  55. Study start A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07900633

  56. Study start Intravenous Thrombolysis, Endovascular Treatment, or Bridging Therapy for Medium Vessel Occlusion Stroke Within 24 Hours Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07931807

  57. Study start Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932314

  58. Study start Personalized Antiplatelet Therapy to Prevent Recurrent Cardiovascular Events in After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07943026

  59. Study start Conduction System Pacing Versus Conventional Right Ventricular Pacing in Adults With Atrioventricular Block Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07945860

  60. Study start BHB-1893 vs. Placebo for Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07946107

  61. Study start Leveraging Telemedicine to Improve Guideline-Directed Medical Therapy Use and Outcomes Among Rural Patients With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07946679

  62. Study start Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07915687

  63. Primary completion A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06539689

  64. Study completion A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05757869

  65. Primary completion A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05757869

  66. Study completion Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04398654

  67. Primary completion Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05686642

  68. Study completion PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06630923

  69. Study completion Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05686642

  70. Primary completion A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07729475

  71. Study completion Wearable Airbag Technology to Mitigate Falls in Individuals With High Fall Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05076565

  72. Primary completion Wearable Airbag Technology to Mitigate Falls in Individuals With High Fall Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05076565

  73. Study completion Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06122779

  74. Primary completion Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06122779

  75. Primary completion Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04029363

  76. Study completion CRP Apheresis in STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04939805

  77. Study completion Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06605209

  78. Primary completion Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06791629

  79. Study start Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07756398

  80. Study start INTRA-ARTERIAL MeVO TREATMENT (IMP-ACT) Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07906275

  81. Study completion French eCLIPs™ Efficacy and Safety Investigation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05330897

  82. Primary completion Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06478186

  83. Study completion CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06601166

  84. Study completion Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03565913

  85. Study completion Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05955326

  86. Primary completion Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05955326

  87. Study completion A Study of VCT220 in Participants With Hypertension and Obesity or Overweight Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07360275

  88. Study start A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07930507

  89. Primary completion Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07521475

  90. Primary completion Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07073768

  91. Study completion Dynamic Stabilometry Combined With Transcranial Direct Current Stimulation for Balance and Motor Recovery After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07912151

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes Registry record

    Expected 2014-01; that period ended on 2014-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01970046

  2. Primary completion The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease Registry record

    Expected 2014-02; that period ended on 2014-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01508663

  3. Primary completion LUCAS Chest Compressor Versus Manual Chest Compression in Out-of-hospital Sudden Cardiac Arrest. LUCAT Trial Registry record

    Expected 2014-02; that period ended on 2014-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01521208

  4. Study completion Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy Registry record

    Expected 2014-02; that period ended on 2014-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01722513

  5. Study completion Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR Registry record

    Expected 2014-02; that period ended on 2014-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01761656

  6. Study completion Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine Registry record

    Expected 2014-02; that period ended on 2014-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01956786

  7. Study completion Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy Registry record

    Expected 2014-03; that period ended on 2014-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01265303

  8. Primary completion Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy Registry record

    Expected 2014-03; that period ended on 2014-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01265303

  9. Study completion Telemetric Arrhythmia Diagnosis in Adults Registry record

    Expected 2014-03; that period ended on 2014-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01265758

  10. Primary completion Telemetric Arrhythmia Diagnosis in Adults Registry record

    Expected 2014-03; that period ended on 2014-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01265758

  11. Study completion Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction Registry record

    Expected 2014-03; that period ended on 2014-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01357317

  12. Study completion Sodium Bicarbonate in Cardiopulmonary Resuscitation Registry record

    Expected 2014-03; that period ended on 2014-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01377337

  13. Primary completion Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity Registry record

    Expected 2014-03; that period ended on 2014-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01567774

  14. Study completion Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus Registry record

    Expected 2014-04; that period ended on 2014-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT00737152

  15. Primary completion Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus Registry record

    Expected 2014-04; that period ended on 2014-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT00737152

  16. Study completion PRISM Cardiac Resynchronisation Therapy (CRT) Randomised Controlled Trial Registry record

    Expected 2014-04; that period ended on 2014-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01429753

  17. Primary completion PRISM Cardiac Resynchronisation Therapy (CRT) Randomised Controlled Trial Registry record

    Expected 2014-04; that period ended on 2014-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01429753

  18. Study completion LUCAS Chest Compressor Versus Manual Chest Compression in Out-of-hospital Sudden Cardiac Arrest. LUCAT Trial Registry record

    Expected 2014-04; that period ended on 2014-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01521208

  19. Primary completion Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy Registry record

    Expected 2014-04; that period ended on 2014-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01673204

  20. Primary completion Fluvastatin AmelIorates aTHerosclerosis Study Registry record

    Expected 2014-04; that period ended on 2014-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01681199

  21. Primary completion Safety Study of Melatonin in Stroke Patients Registry record

    Expected 2014-04; that period ended on 2014-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01863277

  22. Study completion Balloon Elution and Late Loss Optimization (BELLO) Study Registry record

    Expected 2014-05; that period ended on 2014-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01086579

  23. Primary completion PROximal Protection VErsus NON-Protection in Carotid Artery Stenting Registry record

    Expected 2014-05; that period ended on 2014-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01331473

  24. Study completion Creative Therapy to Affect Stroke Outcomes Registry record

    Expected 2014-05; that period ended on 2014-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01455155

  25. Primary completion Dietary Intervention in Diabetes Mellitus (DIDM)- Intermediate and Acute Effects Registry record

    Expected 2014-05; that period ended on 2014-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01585818

  26. Primary completion Effects of Intensive Statin Treatment on Left Ventricular Function Registry record

    Expected 2014-05; that period ended on 2014-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01936103

  27. Primary completion Electronically Connected Health Coaching in Type 2 Diabetes Registry record

    Expected 2014-05; that period ended on 2014-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02036892

  28. Study completion PROximal Protection VErsus NON-Protection in Carotid Artery Stenting Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01331473

  29. Study completion Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01490255

  30. Primary completion Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01490255

  31. Primary completion COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial) Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01552187

  32. Primary completion Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01610141

  33. Study completion Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01736735

  34. Primary completion Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01736735

  35. Primary completion Determination of Instantaneous Wave-Free Ratio by Computed Tomography Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01747031

  36. Study completion Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01758471

  37. Primary completion Efficacy and Safety of Mildronate for Acute Ischemic Stroke Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01800357

  38. Study completion Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01978405

  39. Primary completion Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01978405

  40. Study completion Electronically Connected Health Coaching in Type 2 Diabetes Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02036892

  41. Study completion Endothelial Progenitors in Aortic Stenosis: Association With Aortic Stenosis Progression and Severity Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02060071

  42. Study completion The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02105519

  43. Primary completion The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis Registry record

    Expected 2014-06; that period ended on 2014-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02105519

  44. Primary completion Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01273337

  45. Primary completion Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01372930

  46. Study completion COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial) Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01552187

  47. Primary completion Residual Platelet Activity In Advanced Peripheral Artery Disease Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01627431

  48. Study completion Resistant Hypertension Optimal Treatment Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01643434

  49. Primary completion Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent in Diabetic Patients Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01710748

  50. Study completion Effects of Intensive Statin Treatment on Left Ventricular Function Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01936103

  51. Study completion The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01978730

  52. Primary completion The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01978730

  53. Primary completion Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Registry record

    Expected 2014-07; that period ended on 2014-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02132234

  54. Study completion Dietary Intervention in Diabetes Mellitus (DIDM)- Intermediate and Acute Effects Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01585818

  55. Primary completion Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01653600

  56. Study completion Fluvastatin AmelIorates aTHerosclerosis Study Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01681199

  57. Study completion Determination of Instantaneous Wave-Free Ratio by Computed Tomography Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01747031

  58. Study completion Efficacy and Safety of Mildronate for Acute Ischemic Stroke Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01800357

  59. Primary completion N-Acetyl Cystein and Contrast Nephropathy Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01820195

  60. Study completion Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01851759

  61. Primary completion Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01851759

  62. Study completion Efficacy and Safety of TELMINUVO to Stage 2 Hypertension Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01983735

  63. Primary completion Efficacy and Safety of TELMINUVO to Stage 2 Hypertension Registry record

    Expected 2014-08; that period ended on 2014-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01983735

  64. Primary completion Effect of CPAP on Biomarkers in Patients With OSA Registry record

    Expected 2014-09; that period ended on 2014-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01138865

  65. Primary completion Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease Registry record

    Expected 2014-09; that period ended on 2014-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01179126

  66. Study completion Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery Registry record

    Expected 2014-09; that period ended on 2014-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01431222

  67. Primary completion Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel Registry record

    Expected 2014-09; that period ended on 2014-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01643031

  68. Primary completion Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure Registry record

    Expected 2014-09; that period ended on 2014-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01829152

  69. Primary completion Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis Registry record

    Expected 2014-09; that period ended on 2014-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01923012

  70. Primary completion FREERIDE STUDY, Freeway Paclitaxel Coated Balloon Catheter to Treat Peripheral Artery Disease Registry record

    Expected 2014-09; that period ended on 2014-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01960647

  71. Study completion Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care Registry record

    Expected 2014-10; that period ended on 2014-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01410383

  72. Study completion Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel Registry record

    Expected 2014-10; that period ended on 2014-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01643031

  73. Study completion Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent in Diabetic Patients Registry record

    Expected 2014-10; that period ended on 2014-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01710748

  74. Study completion Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure Registry record

    Expected 2014-10; that period ended on 2014-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01829152

  75. Primary completion Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus Registry record

    Expected 2014-10; that period ended on 2014-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01954147

  76. Primary completion Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL) Registry record

    Expected 2014-10; that period ended on 2014-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02076516

  77. Study completion Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01252420

  78. Primary completion Renal Denervation in Patients With Uncontrolled Hypertension in Chinese Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01390831

  79. Primary completion Sildenofil in Persistent Pulmonary Hypertension in Newborns Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01558466

  80. Study completion N-Acetyl Cystein and Contrast Nephropathy Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01820195

  81. Primary completion Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01951079

  82. Study completion Dexmedetomidine for Catheter-related Bladder Discomfort Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01991223

  83. Primary completion Dexmedetomidine for Catheter-related Bladder Discomfort Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01991223

  84. Study completion Effectiveness of Pediatric Resuscitation Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02283034

  85. Primary completion Effectiveness of Pediatric Resuscitation Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02283034

  86. Study completion Endotracheal Intubation During Resuscitation Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02286323

  87. Primary completion Endotracheal Intubation During Resuscitation Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02286323

  88. Study completion Effectiveness of Child Intubation Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02289638

  89. Primary completion Effectiveness of Child Intubation Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02289638

  90. Study completion Pediatric Intubation During CPR Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02289677

  91. Primary completion Pediatric Intubation During CPR Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02289677

  92. Primary completion Video-laryngoscopy During Chest Compression Registry record

    Expected 2014-11; that period ended on 2014-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02293226

  93. Study completion Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension Registry record

    Expected 2014-12; that period ended on 2014-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT00994617

  94. Primary completion Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension Registry record

    Expected 2014-12; that period ended on 2014-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT00994617

  95. Study completion Early Warning and Optimization Strategy in Carotid Endarterectomy Registry record

    Expected 2014-12; that period ended on 2014-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01210937

  96. Study completion Latin America Cardiac Resynchronization Therapy Study Registry record

    Expected 2014-12; that period ended on 2014-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01238874

  97. Primary completion The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients Registry record

    Expected 2014-12; that period ended on 2014-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01270191

  98. Primary completion The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients Registry record

    Expected 2014-12; that period ended on 2014-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01278498

  99. Primary completion Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China Registry record

    Expected 2014-12; that period ended on 2014-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01341353

  100. Primary completion Customized Choice of Oral P2Y12 Receptor Blocker Registry record

    Expected 2014-12; that period ended on 2014-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01477775